SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-011618
Filing Date
2024-08-08
Accepted
2024-08-08 16:23:57
Documents
17
Period of Report
2024-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K chrs-20240807x8k.htm   iXBRL 8-K 44486
2 EX-99.1 chrs-20240807xex99d1.htm EX-99.1 355616
3 GRAPHIC chrs-20240807xex99d1001.jpg GRAPHIC 6713
  Complete submission text file 0001558370-24-011618.txt   591832

Data Files

Seq Description Document Type Size
4 EX-101.SCH chrs-20240807.xsd EX-101.SCH 4526
5 EX-101.DEF chrs-20240807_def.xml EX-101.DEF 3156
6 EX-101.LAB chrs-20240807_lab.xml EX-101.LAB 12262
7 EX-101.PRE chrs-20240807_pre.xml EX-101.PRE 11149
19 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20240807x8k_htm.xml XML 4855
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 241188794
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)